Valacyclovir vs Avanafil: side-by-side comparison
Valacyclovir (Nucleoside antiviral prodrug) and Avanafil (Phosphodiesterase type 5 (PDE5) inhibitor) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Valacyclovir | Avanafil |
|---|---|---|
| Therapeutic class | Nucleoside antiviral prodrug | Phosphodiesterase type 5 (PDE5) inhibitor |
| CAS | 124832-26-4 | 330784-47-9 |
| ATC | J05AB11 | G04BE10 |
| Molecular weight | 324.34 g/mol | 483.95 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Valacyclovir and Avanafil share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Valacyclovir acts by a different mechanism than Avanafil, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Valacyclovir: Valacyclovir is rapidly and almost completely converted to acyclovir during first-pass intestinal and hepatic metabolism by valacyclovir hydrolase. Avanafil: Avanafil selectively inhibits phosphodiesterase type 5 (PDE5) in the corpus cavernosum, increasing cGMP and enhancing nitric-oxide-mediated vasodilation in response to sexual stimulation.
Indications compared
Valacyclovir: Valacyclovir is approved in adults for the treatment of herpes simplex virus infections, including genital herpes (initial episodes, recurrent episodes and suppressive therapy), herpes labialis (single-day high-dose regi… Avanafil: Avanafil is approved for erectile dysfunction in adult men.
Safety profile
Valacyclovir: Common adverse effects include headache, nausea, abdominal pain and dizziness. Avanafil: The most common adverse effects are headache, flushing, nasal congestion and back pain — typical of the PDE5 class but generally less frequent than with older agents.
Frequently asked questions
Is Valacyclovir better than Avanafil? ▾
Valacyclovir and Avanafil are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Valacyclovir and Avanafil be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Valacyclovir
Products with Avanafil
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.